Results 11 to 20 of about 5,793,605 (328)
Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium
Emerging Infectious Diseases, 2017 Escalating resistance to azithromycin and moxifloxacin is being reported for Mycoplasma genitalium in the Asia-Pacific region. Analyzing 140 infections, we found pretreatment fluoroquinolone-resistance mutations in parC (13.6%) and gyrA (5%).
Gerald L. Murray +7 more
doaj +4 more sources
Antibiotics, 2021 (1) Background: It is unclear what underpins the large global variations in the prevalence of fluoroquinolone resistance in Gram-negative bacteria. We tested the hypothesis that different intensities in the use of quinolones for food-animals play a role.
Chris Kenyon
doaj +2 more sources
Fluoroquinolone Resistance in Escherichia coli Causing Community-Acquired Urinary Tract Infections: A Systematic Review. [PDF]
MicroorganismsCommunity-acquired urinary tract infections account for 15% of all outpatient use of antibiotics, and women are primarily affected; the major causative microorganism is uropathogenic Escherichia coli (E. coli).
Ruiz-Lievano AP +5 more
europepmc +3 more sources
Fluoroquinolone Resistance among Clonal Complex 1 Group B Streptococcus Strains [PDF]
Canadian Journal of Infectious Diseases and Medical Microbiology, 2016 Fluoroquinolone resistance in group B Streptococcus is increasingly being reported worldwide. Here, we correlated fluoroquinolone resistance with mutations in gyrA, gyrB, parC, and parE genes, identified by mining whole-genome sequencing (WGS) data of ...
Alefiya Neemuchwala +3 more
doaj +3 more sources
Trends in fluoroquinolone resistance in Campylobacter [PDF]
Microbial Genomics, 2018 Members of the genus Campylobacter remain a leading cause of bacterial gastroenteritis worldwide. Infection is usually self-limiting but in severe cases may require antibiotic treatment. In a recent statement by the World Health Organization (WHO) Campylobacter was named as one of the 12 bacteria that pose the greatest threat to human health because ...
Sproston, Emma L. +2 more
openaire +3 more sources
Scientific ReportsFluoroquinolone resistance is a major challenge in treating Multidrug-Resistant Tuberculosis globally. The GenoType MTBDRsl Ver 2.0, endorsed by the WHO, was used to characterize fluoroquinolone resistance. The fluoroquinolone resistance rates in the MDR-
Vijayalakshmi Jawaharlal Nehru +7 more
doaj +2 more sources
Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use [PDF]
Interdisciplinary Perspectives on Infectious Diseases, 2012 This paper on the fluoroquinolone resistance epidemiology stratifies the data according to the different prescription patterns by either primary or tertiary caregivers and by indication.
Axel Dalhoff
doaj +2 more sources
Antibiotics, 2022 Background: Extremely low concentrations of ciprofloxacin may select for antimicrobial resistance. A recent global survey found that ciprofloxacin concentrations exceeded safe levels at 64 sites. In this study, I assessed if national median ciprofloxacin
Chris Kenyon
doaj +2 more sources
Scientific Reports, 2021 Stenotrophomonas maltophilia exhibits wide spectrum of fluoroquinolone resistance using different mechanisms as multidrug efflux pumps and Smqnr alleles.
Akram Azimi +5 more
doaj +2 more sources
Fluoroquinolone resistance in multidrug-resistantMycobacterium tuberculosisindependent of fluoroquinolone use [PDF]
European Respiratory Journal, 2017 Fluoroquinolone resistance in multidrug-resistant tuberculosis develops with various anti-tuberculosis regimens http://ow.ly ...
Yang, Che +4 more
openaire +3 more sources